17β-estradiol exerts a beneficial effect on coronary vascular remodeling in the early stages of hypertension in spontaneously hypertensive rats

Menopause

Volumn 12, Issue 4, 2005, Pages 453-459

  Garcia, Paz M ^a   Giménez, Jose ^a   Bonacasa, Barbara ^a   Carbonell, Luis F ^a   Miguel, Salom G ^a   Quesada, Tomas ^a   Hernández, Isabel ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Estrogen; Mitogen activated protein kinase; Spontaneously hypertensive rats; Vascular remodeling

Indexed keywords

ESTRADIOL; ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY WALL; ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DRUG EFFECT; HEART PROTECTION; HEART VENTRICLE REMODELING; HYPERTENSION; MESENTERIC ARTERY; NONHUMAN; OVARIECTOMY; RAT; RISK BENEFIT ANALYSIS; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; ENZYMOLOGY; FEMALE; FIBROSIS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TUNICA MEDIA; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CORONARY VESSELS; ESTRADIOL; FEMALE; FIBROSIS; HYPERTENSION; MESENTERIC ARTERIES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TUNICA MEDIA;

EID: 23244441698     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000151654.10243.01     Document Type: Article

References (32)

1. Oparil S, Levine RL, Cchen YF. Sex hormones and the vasculature. In: Sowers JR, Walsh M, ed. Endocrinology of the Vasculature. Totowa, NJ: Humana Press, 1996:225-237.
2. Heagerty AM, Aalkjaer C, Bund ST, Kosgaard N, Mulvany MJ. Small artery structure in hypertension: dual processes of remodeling and growth. Hypertension 1993;21:931-937.
3. Intengan HD, Schiffrin EL. Vascular remodeling in hypertension. Roles of apoptosis, inflammation and fibrosis. Hypertension 2001;38:581-587.
4. Orimo A, Inoue S, Ouchi Y, Orimo H. Vascular smooth muscle cells possess estrogen receptors and respond to estrogen. Ann NY Acad Sci 1995;748:592-594.
5. Farhat MY, Abi-Younes S, Ramwell PW. Non-genomic effects of estrogen and the vessel wall. Biochem Pharmacol 1996;51:571-576.
6. Oparil S, Levine R, Chen S-J, Durand J, Chen YF. Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment. Circulation 1997;95:1301-1307.
7. Foegh ML, Asotra S, Howell MH, Ramwell PW. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg 1994;19:722-726.
8. Force T, Bonventre JV. Growth factors and mitogen-activated protein kinases. Hypertension 1998;31:152-161.
9. Dubey KR, Jackson EK, Gillespie DG, Zacharia LC, Imthurn B, Keller PJ. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity. Arterioscler Thromb Vasc Biol 2000;20:964-972.
10. Oparil S, Franco V. Hormone replacement therapy and hypertension. Curr Opin Nephrol Hypertens 2001;11:229-235.
11. Rossouw JE, Anderson GL, Prentice RL, et al. Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
12. Anderson GL, Limacher M, Assaf AR, et al [Women's Health Initiative Steering Committee]. Effect of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-1712.
13. Hodis HN, Mack WJ, Azen SP, et al. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med 2003;349:535-545.
14. Hernández I, Delgado JL, Díaz J, et al. 17β-Estradiol prevents oxidative stress and decreases blood pressure in ovariectomized rats. Am J Physiol Regul Integr Comp Physiol 2000;279:R1599-R1605.
15. Touyz RM, He G, Deng LY, Schiffrin EL. Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries. Circulation 1999;99:392-399.
16. Shiffrin EL. Reactivity of small blood vessels in hypertension: relationship with structural changes. Hypertension 1992;19:II1-II9.
17. 1 receptor and salt sensitivity. Hypertension 2003;42:1157-1163.
18. Reckelhoff JF, Zhang H, Srivastava K. Gender differences in the development of hypertension in SHR: role of the renin-angiotensin system. Hypertension 2000;35:480-483.
19. Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res 2002;53:688-708.
20. Cambotti LJ, Cole FE, Gerall AA, Frohlich ED, MacPhee AA. Neonatal gonadal hormones and blood pressure in the spontaneously hypertensive rat. Am J Physiol 1984;247:E258-E264
21. Sharkey LC, Holycross BJ, Park S, et al. Effect of ovariectomy and estrogen replacement on cardiovascular disease in heart failure SHHF/Mac-facp rats. J Mol Cell Cardiol 1999;31:1527-1537.
22. Crofton JT, Share L. Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats. Hypertension 1997;29:494-499.
23. Sasaki T, Ohno Y, Otsuka K, Suzawa T, Suzuki H, Saruta T. Oestrogen attenuates the increases in blood pressure and platelet aggregation in ovariectomized and salt-loaded Dahl salt-sensitive rats. J Hypertens 2000;18:911-917.
24. Dubey RK, Gillespie DG, Zacharia LC, Barchiesi F, Imthurn B, Jackson EK. CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs. Hypertension 2003;41(3 Pt 2):807-813.
25. Silbiger S, Lei J, Ziyadeg FN, Neugarten J. Estradiol reverses TGF-β1-stimulated type IV collagen gene transcription in murine mesangial cells. Am J Physiol 1998;274:F113-F118.
26. Wingrove CS, Garr E, Godsland IF, Stevenson JC. 17beta;-estradiol enhances release of matrix metalloproteinasse-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1998;1406:169-174.
27. Dubey RK, Jackson EK. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol Renal Physiol 2001;280:F365-F388.
28. Mendelsohn ME, Karas RH. The protective effect of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.
29. Takeda-Matsubara Y, Nakagami H, Iwai M, et al. Estrogen activates phosphatases and antagonizes growth-promoting effects of angiotensin II. Hypertension 2002;39:41-45.
30. Liu HW, Takeda-Matsubara Y, Wu L, et al. Effect of estrogen and AT1 receptor blocker on neointima formation. Hypertension 2002;40:451-457.
31. Herrington DM, Reboussin DM, Brosnihan KB, et al. Effects of estrogen replacement therapy on the progression of coronary-artery atherosclerosis. N Engl J Med 2000;343:522-529.
32. Herrington DM, Espeland MA, Crouse JR III, et al. Estrogen replacement and brachial artery flow-mediated vasodilatation in older women. Arterioscler Thromb Vasc Biol 2001;21:1955-1961.